We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,352.00
Bid: 11,348.00
Ask: 11,350.00
Change: 84.00 (0.75%)
Spread: 2.00 (0.018%)
Open: 11,288.00
High: 11,412.00
Low: 11,288.00
Prev. Close: 11,268.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

23 Dec 2020 16:06

UPDATE 1-New COVID-19 variant detected in Israel, health ministry says

(Adds details, context)TEL AVIV, Dec 23 (Reuters) - Israel has detected four cases of the new, highly infectious variant of the coronavirus that has emerged in Britain, the Israeli health ministry said on Wednesday.Three of the cases were returnee...

Read more
23 Dec 2020 15:17

AstraZeneca submitted date for vaccine approval, UK's Hancock says

LONDON, Dec 23 (Reuters) - British Health Minister Matt Hancock said on Wednesday that AstraZeneca had submitted a full data package about its COVID-19 vaccine to the medicines regulator, the next step in its journey to approval for use."I'm delig...

Read more
23 Dec 2020 15:17

REFILE-AstraZeneca submitted data for vaccine approval, UK's Hancock says

(Refiles to correct typo in headline)LONDON, Dec 23 (Reuters) - British Health Minister Matt Hancock said on Wednesday that AstraZeneca had submitted a full data package about its COVID-19 vaccine to the medicines regulator, the next step in its j...

Read more
23 Dec 2020 07:47

UPDATE 2-Tropical Malaysia works to boost cold-storage, get more COVID-19 shots

* Delivery map for vaccines needing ultra-cold storage* Final talks with Russian and Chinese vaccine makers* Aims to double AstraZeneca vaccines, buy more from Pfizer* In talks with Moderna Inc, Johnson & Johnson (Recasts, adds details on vaccine lo...

Read more
23 Dec 2020 07:00

Production and delivery challenges set up turbulent Year of the Vaccine

* Pfizer, Moderna to make at least 1.8 bln shots combined in 2021* IFPMA sees up to 10 vaccines approved by mid-2021* Production may lag demand well into 2022By John MillerZURICH, Dec 23 (Reuters) - As 2020 closes, regulatory approval of COVID-19 v...

Read more
22 Dec 2020 22:29

UPDATE 1-Drugmakers expect tests to confirm vaccines effective against new coronavirus variant

(Adds AstraZeneca saying its vaccine should be effective against new variant)By John Miller and Patricia WeissZURICH/FRANKFURT, Dec 22 (Reuters) - At least four drugmakers expect their COVID-19 vaccines will be effective against the new fast-sprea...

Read more
22 Dec 2020 22:03

UPDATE 1-Brazil Health Ministry expects at least 150 mln vaccine doses by June

(Adds details of vaccine delivery, pending deals)By Lisandra ParaguassuBRASILIA, Dec 22 (Reuters) - Brazil's Health Ministry expects to have at least 150 million doses of vaccines against COVID-19 available in the first half of 2021, with a third o...

Read more
22 Dec 2020 21:21

Amgen, Astra's Tezepelumab Falls Short Of Primary Endpoint

Amgen, Astra's Tezepelumab Falls Short Of Primary Endpoint

Read more
22 Dec 2020 20:58

UPDATE 1-AstraZeneca says its vaccine should be effective against new coronavirus variant

(Adds background of variant, AstraZeneca's vaccine, adds comments by AstraZeneca representative)By Kanishka SinghDec 22 (Reuters) - British drugmaker AstraZeneca Plc told Reuters on Tuesday its COVID-19 vaccine should be effective against the new ...

Read more
22 Dec 2020 20:19

AstraZeneca says its vaccine should be effective against new coronavirus variant

Dec 22 (Reuters) - British drugmaker AstraZeneca Plc told Reuters on Tuesday that its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation."AZD1222 ...

Read more
22 Dec 2020 10:10

UPDATE 2-UK stocks recover on Brexit progress hopes after virus-led pullback

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Britain's fishing rights offer raises hopes for a deal* UK economy recovers 16% in Q3, recession risks loom* AstraZeneca down as asthma dru...

Read more
22 Dec 2020 10:05

UPDATE 2-European shares rebound as Brexit trade deal progress overshadows virus worries

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Britain-EU rifts over fishing narrow* U.S. Congress approves $892 bln pandemic aid package* Tech stocks, banks lead broad-based gains in Eu...

Read more
21 Dec 2020 17:29

Fifty million people in U.S. to have first COVID-19 shot by end January - Azar

NEW YORK, Dec 21 (Reuters) - About 50 million people in the United States will have had the first of two COVID-19 shots needed for immunization by the end of January, the U.S. Department of Health and Human Services Secretary Alex Azar said on Mo...

Read more
21 Dec 2020 17:08

WHO sees limited rollout of Pfizer vaccine by end-Jan

GENEVA/ZURICH, Dec 21 (Reuters) - The World Health Organization expects to give emergency use approval for the COVID-19 vaccine developed by Pfizer and its German partner BioNTech this month, with a limited roll-out starting by late January, offi...

Read more
21 Dec 2020 16:11

Colombia to receive 1.7 million doses of Pfizer/BioNTech vaccine in February

By Julia Symmes CobbBOGOTA, Dec 21 (Reuters) - Colombia will receive its first shipment of COVID-19 vaccines developed by Pfizer Inc and BioNTech SE in February, the country health ministry said on Monday.The 1.7 million doses are enough to vaccin...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.